The VELETRI Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The VELETRI global market has experienced robust growth in past years. The market size is projected to expand from $1.34 billion in 2024 to $1.45 billion in 2025, representing a compound annual growth rate (CAGR) of 7.9%.
The VELETRI market is projected to reach $1.95 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.7%.
Download Your Free Sample of the 2025 VELETRI Market Report and Uncover Key Trends Now!The key drivers in the veletri market are:
• Increasing prevalence of venous diseases driving a need for VELETRI
• Growing awareness and early diagnosis of these diseases
• Rising expenditure on chronic diseases
• Improvement and expansion of healthcare infrastructure
The veletri market covered in this report is segmented –
1) By Product Type: Injectable, Inhalation
2) By Application: Pulmonary Arterial Hypertension, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Injectable: Intravenous (IV) Injection, Subcutaneous (SC) Injection
2) By Inhalation: Nebulized Inhalation, Dry Powder Inhalation
The key trends in the veletri market are:
• Technological advancements are set to shape the future of the VELETRI market.
• Increased collaborations between pharmaceutical companies and research institutions will play a significant role.
• An upcoming trend is the robust pipeline of clinical research.
• The entrance of biosimilars and generics into the market is a significant emerging trend.
Major players in the veletri market are:
• Johnson & Johnson
• Bayer Pharma AG
• Novartis AG
• GlaxoSmithKline plc
• Gilead Sciences Inc.
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Sandoz International GmbH
• Sun Pharmaceutical Industries Ltd.
• Actelion Pharmaceuticals Ltd.
• Euroapi S.A.
• United Therapeutics Corporation
• Pfizer CentreOne
• Sai Life Sciences Limited
• Zhejiang Ausun Pharmaceutical Co. Ltd.
• Yonsung Fine Chemicals Co. Ltd.
• Cayman Pharma S.r.o.
• Meitheal Pharmaceuticals Inc.
• Smiths Medical
• Guangzhou Tosun Pharmaceutical Co. Ltd.
North America was the largest region in the VELETRI market in 2024